Characterization and in vitro and in vivo evaluation of tacrolimus-loaded poly(ε-caprolactone) nanocapsules for the management of atopic dermatitis

Authors

Guilherme Dos Anjos Camargo, Universidade Estadual de Ponta Grossa
Leandro Ferreira, Universidade Estadual de Ponta Grossa
Diego José Schebelski, Universidade Estadual de Ponta Grossa
Amanda Martinez Lyra, Universidade Estadual de Ponta Grossa

Document Type

Article

Publication Date

12-1-2021

Abstract

Background: Tacrolimus (TAC) is a drug of natural origin used in conventional topical dosage forms to control atopic dermatitis. However, direct application of the drug often causes adverse side effects in some patients. Hence, drug nanoencapsulation could be used as an improved novel therapy to mitigate the adverse effects and enhance bioavailability of the drug. Methods: Physicochemical properties, in vitro drug release experiments, and in vivo anti-inflammatory activity studies were performed. Results: TAC-loaded nanocapsules were successfully prepared by the interfacial deposition of preformed polymer using poly(ε-caprolactone) (PCL). The nanoparticu-late systems presented a spherical shape with a smooth and regular surface, adequate diameter (226 to 250 nm), polydispersity index below 0.3, and suitable electrical stability (−38 to −42 mV). X-ray diffraction confirmed that the encapsulation method provided mainly the drug molecular dispersion in the nanocapsule oily core. Fourier-transform infrared spectra suggested that nanoen-capsulation did not result in chemical bonds between drug and polymer. In vitro drug dissolution experiments showed a controlled release with a slight initial burst. The release kinetics showed zero-order kinetics. As per the Korsmeyer–Peppas model, anomalous transport features were observed. TAC-loaded PCL nanocapsules exhibited excellent anti-inflammatory activity when compared to the free drug. Conclusions: TAC-loaded PCL nanocapsules can be suitably used as a novel nano-based dosage form to control atopic dermatitis.

Relational Format

journal article

Recommended Citation

Camargo, G.d.A.; Ferreira, L.; Schebelski, D.J.; Lyra, A.M.; Barboza, F.M.; Carletto, B.; Koga, A.Y.; Semianko, B.C.; Dias, D.T.; Lipinski, L.C.; et al. Characterization and In Vitro and In Vivo Evaluation of Tacrolimus-Loaded Poly(ε-Caprolactone) Nanocapsules for the Management of Atopic Dermatitis. Pharmaceutics 2021, 13, 2013. https://doi.org/10.3390/pharmaceutics13122013

DOI

10.3390/pharmaceutics13122013

Accessibility Status

Searchable text